Investor Name | Invest Money | Lead Investor | Propotion | |
---|---|---|---|---|
Mubadala Capital Ventures | - | Yes | - | Detail |
ARCH Venture Partners | - | - | - | Detail |
Abu Dhabi Growth Fund | - | - | - | Detail |
Altitude Life Science Ventures | - | - | - | Detail |
Amgen | - | - | - | Detail |
EXOR N.V. | - | - | - | Detail |
F-Prime Capital | - | - | - | Detail |
Invus | - | - | - | Detail |
Newpath Management | - | - | - | Detail |
Polaris Partners | - | - | - | Detail |
Announced Date | Round | Money Raised | Investors | |
---|---|---|---|---|
Oct 7, 2021 | Series A | $ 400M | ARCH Venture Partners,Alexandria Venture Investments,etc. | Detail |
Oct 7, 2021 | Corporate Round | $ 100M | Amgen | Detail |